Literature DB >> 19672284

Association of the TGF-beta receptor genes with abdominal aortic aneurysm.

A F Baas1, J Medic, R van 't Slot, C G de Kovel, A Zhernakova, R H Geelkerken, S E Kranendonk, S M van Sterkenburg, D E Grobbee, A P Boll, C Wijmenga, J D Blankensteijn, Y M Ruigrok.   

Abstract

Abdominal aortic aneurysm (AAA) is a multifactorial condition. The transforming growth factor beta (TGF-beta) pathway regulates vascular remodeling and mutations in its receptor genes, TGFBR1 and TGFBR2, cause syndromes with thoracic aortic aneurysm (TAA). The TGF-beta pathway may be involved in aneurysm development in general. We performed an association study by analyzing all the common genetic variants in TGFBR1 and TGFBR2 using tag single nucleotide polymorphisms (SNPs) in a Dutch AAA case-control population in a two-stage genotyping approach. In stage 1, analyzing 376 cases and 648 controls, three of the four TGFBR1 SNPs and nine of the 28 TGFBR2 SNPs had a P<0.07. Genotyping of these SNPs in an independent cohort of 360 cases and 376 controls in stage 2 confirmed association (P<0.05) for the same allele of one SNP in TGFBR1 and two SNPs in TGFBR2. Joint analysis of the 736 cases and 1024 controls showed statistically significant associations of these SNPs, which sustained after proper correction for multiple testing (TGFBR1 rs1626340 OR 1.32 95% CI 1.11-1.56 P=0.001 and TGFBR2 rs1036095 OR 1.32 95% CI 1.12-1.54 P=0.001 and rs4522809 OR 1.28 95% CI 1.12-1.46 P=0.0004). We conclude that genetic variations in TGFBR1 and TGFBR2 associate with AAA in the Dutch population. This suggests that AAA may develop partly by similar defects as TAA, which in the future may provide novel therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672284      PMCID: PMC2987181          DOI: 10.1038/ejhg.2009.141

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  30 in total

Review 1.  Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors.

Authors:  P ten Dijke; K Miyazono; C H Heldin
Journal:  Curr Opin Cell Biol       Date:  1996-04       Impact factor: 8.382

Review 2.  Molecular genetics of Marfan syndrome.

Authors:  Catherine Boileau; Guillaume Jondeau; Takeshi Mizuguchi; Naomichi Matsumoto
Journal:  Curr Opin Cardiol       Date:  2005-05       Impact factor: 2.161

3.  Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm.

Authors:  Gregory T Jones; Victoria L Phillips; Eugenie L Harris; Jeremy I Rossaak; André M van Rij
Journal:  J Vasc Surg       Date:  2003-12       Impact factor: 4.268

4.  High prevalence of abdominal aortic aneurysm in a primary care screening programme.

Authors:  A P Boll; A L Verbeek; E H van de Lisdonk; J A van der Vliet
Journal:  Br J Surg       Date:  1998-08       Impact factor: 6.939

5.  Overexpression of transforming growth factor beta1 in smooth muscle cells of human abdominal aortic aneurysm.

Authors:  D Fukui; S Miyagawa; J Soeda; K Tanaka; H Urayama; S Kawasaki
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-06       Impact factor: 7.069

6.  Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants.

Authors: 
Journal:  Lancet       Date:  1998-11-21       Impact factor: 79.321

7.  Heterozygous TGFBR2 mutations in Marfan syndrome.

Authors:  Takeshi Mizuguchi; Gwenaëlle Collod-Beroud; Takushi Akiyama; Marianne Abifadel; Naoki Harada; Takayuki Morisaki; Delphine Allard; Mathilde Varret; Mireille Claustres; Hiroko Morisaki; Makoto Ihara; Akira Kinoshita; Koh-ichiro Yoshiura; Claudine Junien; Tadashi Kajii; Guillaume Jondeau; Tohru Ohta; Tatsuya Kishino; Yoichi Furukawa; Yusuke Nakamura; Norio Niikawa; Catherine Boileau; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2004-07-04       Impact factor: 38.330

8.  Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.

Authors:  B Lee; M Godfrey; E Vitale; H Hori; M G Mattei; M Sarfarazi; P Tsipouras; F Ramirez; D W Hollister
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

9.  Possible association between genetic polymorphisms in transforming growth factor beta receptors, serum transforming growth factor beta1 concentration and abdominal aortic aneurysm.

Authors:  J Golledge; P Clancy; G T Jones; M Cooper; L J Palmer; A M van Rij; P E Norman
Journal:  Br J Surg       Date:  2009-06       Impact factor: 6.939

Review 10.  Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies.

Authors:  Jacques Cornuz; Claudio Sidoti Pinto; Heindrik Tevaearai; Matthias Egger
Journal:  Eur J Public Health       Date:  2004-12       Impact factor: 3.367

View more
  19 in total

1.  Common variants in TGFBR2 and miR-518 genes are associated with hypertension in the Chinese population.

Authors:  Jinfeng Chen; Xianghai Zhao; Hairu Wang; Yanchun Chen; Wen Wang; Wei Zhou; Xuecai Wang; Junming Tang; Yanping Zhao; Xiangfeng Lu; Shufeng Chen; Laiyuan Wang; Chong Shen; Song Yang
Journal:  Am J Hypertens       Date:  2014-03-31       Impact factor: 2.689

2.  Transforming growth factor-beta signaling pathway in patients with Kawasaki disease.

Authors:  Chisato Shimizu; Sonia Jain; Sonia Davila; Martin L Hibberd; Kevin O Lin; Delaram Molkara; Jeffrey R Frazer; Shelly Sun; Annette L Baker; Jane W Newburger; Anne H Rowley; Stanford T Shulman; Sonia Davila; David Burgner; Willemijn B Breunis; Taco W Kuijpers; Victoria J Wright; Michael Levin; Hariklia Eleftherohorinou; Lachlan Coin; Stephen J Popper; David A Relman; Wen Fury; Calvin Lin; Scott Mellis; Adriana H Tremoulet; Jane C Burns
Journal:  Circ Cardiovasc Genet       Date:  2010-12-02

Review 3.  Genes and abdominal aortic aneurysm.

Authors:  Irene Hinterseher; Gerard Tromp; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2010-12-13       Impact factor: 1.466

4.  Association of gene polymorphisms in MYH11 and TGF-β signaling with the susceptibility and clinical outcomes of DeBakey type III aortic dissection.

Authors:  Yafei Chang; Qinghua Yuan; Yitong Ma; Xiang Ma; Peipei Jiang; Ling Sun
Journal:  Mamm Genome       Date:  2021-11-02       Impact factor: 3.224

5.  Candidate gene analysis of arteriovenous fistula failure in hemodialysis patients.

Authors:  Jeffrey J W Verschuren; Gurbey Ocak; Friedo W Dekker; Ton J Rabelink; J Wouter Jukema; Joris I Rotmans
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 8.237

Review 6.  Ruptured abdominal aortic aneurysm-epidemiology, predisposing factors, and biology.

Authors:  Thomas Schmitz-Rixen; M Keese; M Hakimi; A Peters; D Böckler; K Nelson; R T Grundmann
Journal:  Langenbecks Arch Surg       Date:  2016-03-21       Impact factor: 3.445

7.  Genomic DNA pooling strategy for next-generation sequencing-based rare variant discovery in abdominal aortic aneurysm regions of interest-challenges and limitations.

Authors:  Magdalena Harakalova; Isaäc J Nijman; Jelena Medic; Michal Mokry; Ivo Renkens; Jan D Blankensteijn; Wigard Kloosterman; Annette F Baas; Edwin Cuppen
Journal:  J Cardiovasc Transl Res       Date:  2011-03-01       Impact factor: 4.132

8.  Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease.

Authors:  Yu Mi Choi; Kye Sik Shim; Kyung Lim Yoon; Mi Young Han; Sung Ho Cha; Su Kang Kim; Joo Ho Jung
Journal:  Korean J Pediatr       Date:  2012-01-31

9.  Genomic research to identify novel pathways in the development of abdominal aortic aneurysm.

Authors:  Seamus C Harrison; Anastasia Z Kalea; Michael V Holmes; Obi Agu; Steve E Humphries
Journal:  Cardiol Res Pract       Date:  2012-01-29       Impact factor: 1.866

10.  A Common Polymorphism of the Human Cardiac Sodium Channel Alpha Subunit (SCN5A) Gene Is Associated with Sudden Cardiac Death in Chronic Ischemic Heart Disease.

Authors:  Boglárka Marcsa; Réka Dénes; Krisztina Vörös; Gergely Rácz; Mária Sasvári-Székely; Zsolt Rónai; Klára Törő; Gergely Keszler
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.